scispace - formally typeset
J

Jenny Karlsson

Researcher at Lund University

Publications -  85
Citations -  2457

Jenny Karlsson is an academic researcher from Lund University. The author has contributed to research in topics: Dopaminergic & Transplantation. The author has an hindex of 24, co-authored 74 publications receiving 2223 citations. Previous affiliations of Jenny Karlsson include University of New Mexico & University of Hawaii at Manoa.

Papers
More filters
Journal ArticleDOI

Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Cancer

TL;DR: Findings from this limited case series suggest that complex evolutionary patterns may be associated with a shorter survival in surgically treated PDAC patients.
Journal ArticleDOI

Determination of haemoglobin and prothrombin complex in whole blood using optothermal spectrometry.

TL;DR: The optothermal spectrometry method was found to have acceptable precision and to be comparable to a routine method, and comparisons with reference methods were excellent.
Journal ArticleDOI

High-resolution spectroscopic techniques for studying rare-earth ions in nanoparticles

TL;DR: In this article , the authors present techniques for determining inhomogeneous and homogeneous linewidths of small ensembles of rare-earth ions in doped nanoparticles with high signal-to-noise ratios for convenient integration times.
Journal ArticleDOI

All-optical control of long-lived nuclear spins in rare-earth doped nanoparticles

TL;DR: Optically controlled nuclear spins with long coherence lifetimes (T2) in rare-earth-doped nanoparticles are reported, opening the way to providing quantum light-atom-spin interfaces with long storage time within hybrid architectures.
Journal ArticleDOI

Abstract 1662: Orthotopic model of hepatocellular carcinoma (HCC) using Huh-7 and HepG2: Application of micro-CT in detection of cancer progression

TL;DR: An orthotopic model using intrahepatic approach of cancer cells implantation of HCC utilizing two cell lines Huh-7 and HepG2 is established and provides a promising tool contributing to the development of novel therapies targeting HCC in vivo.